Literature DB >> 24080732

Glucocorticoid sensitivity in health and disease.

Rogier A Quax1, Laura Manenschijn, Jan W Koper, Johanna M Hazes, Steven W J Lamberts, Elisabeth F C van Rossum, Richard A Feelders.   

Abstract

Glucocorticoids regulate many physiological processes and have an essential role in the systemic response to stress. For example, gene transcription is modulated by the glucocorticoid-glucocorticoid receptor complex via several mechanisms. The ultimate biologic responses to glucocorticoids are determined by not only the concentration of glucocorticoids but also the differences between individuals in glucocorticoid sensitivity, which is influenced by multiple factors. Differences in sensitivity to glucocorticoids in healthy individuals are partly genetically determined by functional polymorphisms of the gene that encodes the glucocorticoid receptor. Hereditary syndromes have also been identified that are associated with increased and decreased sensitivity to glucocorticoids. As a result of their anti-inflammatory properties, glucocorticoids are widely used in the treatment of allergic, inflammatory and haematological disorders. The variety in clinical responses to treatment with glucocorticoids reflects the considerable variation in glucocorticoid sensitivity between individuals. In immune-mediated disorders, proinflammatory cytokines can induce localized resistance to glucocorticoids via several mechanisms. Individual differences in how tissues respond to glucocorticoids might also be involved in the predisposition for and pathogenesis of the metabolic syndrome and mood disorders. In this Review, we summarize the mechanisms that influence glucocorticoid sensitivity in health and disease and discuss possible strategies to modulate glucocorticoid responsiveness.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24080732     DOI: 10.1038/nrendo.2013.183

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  214 in total

1.  Expression of the human glucocorticoid receptor splice variants alpha, beta, and P in peripheral blood mononuclear leukocytes in healthy controls and in patients with hyper- and hypocortisolism.

Authors:  Antje Hagendorf; Jan W Koper; Frank H de Jong; Albert O Brinkmann; Steven W J Lamberts; Richard A Feelders
Journal:  J Clin Endocrinol Metab       Date:  2005-08-23       Impact factor: 5.958

2.  Reduced capacity for the reactivation of glucocorticoids in rheumatoid arthritis synovial cells: possible role of the sympathetic nervous system?

Authors:  Martin Schmidt; Claudia Weidler; Heidrun Naumann; Sven Anders; Jürgen Schölmerich; Rainer H Straub
Journal:  Arthritis Rheum       Date:  2005-06

Review 3.  The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings.

Authors:  József Haller; Eva Mikics; Gábor B Makara
Journal:  Front Neuroendocrinol       Date:  2007-10-24       Impact factor: 8.606

4.  Twenty-four-hour ACTH and cortisol pulsatility in depressed women.

Authors:  E A Young; N E Carlson; M B Brown
Journal:  Neuropsychopharmacology       Date:  2001-08       Impact factor: 7.853

5.  DST studies in psychotic depression: a meta-analysis.

Authors:  J C Nelson; J M Davis
Journal:  Am J Psychiatry       Date:  1997-11       Impact factor: 18.112

6.  Seasonal variation in glucocorticoid receptor binding characteristics in human mononuclear leucocytes.

Authors:  G Blackhurst; P K McElroy; R Fraser; R L Swan; J M Connell
Journal:  Clin Endocrinol (Oxf)       Date:  2001-11       Impact factor: 3.478

7.  Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events.

Authors:  K G Saag; R Koehnke; J R Caldwell; R Brasington; L F Burmeister; B Zimmerman; J A Kohler; D E Furst
Journal:  Am J Med       Date:  1994-02       Impact factor: 4.965

8.  Interaction of the glucocorticoid receptor with the chromatin landscape.

Authors:  Sam John; Peter J Sabo; Thomas A Johnson; Myong-Hee Sung; Simon C Biddie; Stafford L Lightman; Ty C Voss; Sean R Davis; Paul S Meltzer; John A Stamatoyannopoulos; Gordon L Hager
Journal:  Mol Cell       Date:  2008-03-14       Impact factor: 17.970

9.  Circadian patterns of stress-induced ACTH secretion are modified by corticosterone responses.

Authors:  W C Engeland; J Shinsako; C M Winget; J Vernikos-Danellis; M F Dallman
Journal:  Endocrinology       Date:  1977-01       Impact factor: 4.736

Review 10.  Dynamic regulation of glucocorticoid signalling in health and disease.

Authors:  Simon C Biddie; Becky L Conway-Campbell; Stafford L Lightman
Journal:  Rheumatology (Oxford)       Date:  2011-09-03       Impact factor: 7.580

View more
  87 in total

Review 1.  Nuclear receptors in neural stem/progenitor cell homeostasis.

Authors:  Dimitrios Gkikas; Matina Tsampoula; Panagiotis K Politis
Journal:  Cell Mol Life Sci       Date:  2017-06-21       Impact factor: 9.261

2.  Functional proteomic analysis of corticosteroid pharmacodynamics in rat liver: Relationship to hepatic stress, signaling, energy regulation, and drug metabolism.

Authors:  Vivaswath S Ayyar; Richard R Almon; Debra C DuBois; Siddharth Sukumaran; Jun Qu; William J Jusko
Journal:  J Proteomics       Date:  2017-03-14       Impact factor: 4.044

3.  Assessment of hair cortisol in euthyroid, hypothyroid, and subclinical hypothyroid subjects.

Authors:  Darya Saeed Abdulateef; Taha Othman Mahwi
Journal:  Endocrine       Date:  2018-09-06       Impact factor: 3.633

4.  Generating diversity in human glucocorticoid signaling through a racially diverse polymorphism in the beta isoform of the glucocorticoid receptor.

Authors:  Shannon D Whirledge; Christine M Jewell; Lisa M Barber; Xiaojiang Xu; Kevin S Katen; Stavros Garantziotis; John A Cidlowski
Journal:  Lab Invest       Date:  2017-07-31       Impact factor: 5.662

5.  Prednisone compared to methylprednisolone in the polymyalgia rheumatica treatment.

Authors:  Ombretta Viapiana; Davide Gatti; Sonila Troplini; Silvano Adami; Elena Fracassi; Luca Idolazzi; Maurizio Rossini
Journal:  Rheumatol Int       Date:  2014-08-23       Impact factor: 2.631

6.  Individual differences in glucocorticoid regulation: Does it relate to disease risk and resilience?

Authors:  Jasmine I Caulfield; Sonia A Cavigelli
Journal:  Front Neuroendocrinol       Date:  2019-11-04       Impact factor: 8.606

7.  Stratified control of IGF-I expression by hypoxia and stress hormones in osteoblasts.

Authors:  Thomas L McCarthy; Zhong Yun; Joseph A Madri; Michael Centrella
Journal:  Gene       Date:  2014-01-15       Impact factor: 3.688

8.  3,4-methylenedioxymethamphetamine (MDMA--Ecstasy) decreases neutrophil activity through the glucocorticoid pathway and impairs host resistance to Listeria monocytogenes infection in mice.

Authors:  V Ferraz-de-Paula; A Ribeiro; J Souza-Queiroz; M L Pinheiro; J F Vecina; D P M Souza; W M Quinteiro-Filho; R L M Moreau; M L S Queiroz; J Palermo-Neto
Journal:  J Neuroimmune Pharmacol       Date:  2014-08-12       Impact factor: 4.147

Review 9.  Monoclonal antibodies: the new magic bullets for allergy: IUPHAR Review 17.

Authors:  N Landolina; F Levi-Schaffer
Journal:  Br J Pharmacol       Date:  2016-02-01       Impact factor: 8.739

10.  Circulating Interleukin-6 concentration covaries inversely with self-reported sleep duration as a function of polymorphic variation in the glucocorticoid receptor.

Authors:  Catherine P Walsh; Alvin Lim; Anna L Marsland; Robert E Ferrell; Stephen B Manuck
Journal:  Brain Behav Immun       Date:  2019-01-11       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.